Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the feasibility, safety, and potential protective benefit of Barrigel, a hyaluronic acid-based rectal spacer, in patients undergoing prostate cryoablation for localized or recurrent prostate cancer. The primary aim is to assess Barrigel thermal stability during cryoablation.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 40-95 lat
- •Potwierdzony biopsją rak prostaty w początkowym stadium lub nawrót choroby
- •Poziom PSA poniżej 20 ng/ml
- •Brak przerzutów raka
- •Zgoda na zabieg kriochirurgii pod narkozą
- •Gotowość do udziału w badaniach kontrolnych i testach krwi po zabiegu
✗ Disqualifies
- •Przerzuty raka
- •Poprzednia radioterapia prostaty
- •Aktywne zapalenie w odbytni lub drogach moczowych
- •Alergia na kwas hialuronowy lub środki kontrastowe
- •Niemożliwość wykonania rezonansu magnetycznego
- •Niechęć do udziału w badaniach kontrolnych
Simplified criteria — AI translation
Trial details
- Minimum age
- 40 Years
- Maximum age
- 95 Years
- Last updated (source)
- July 9, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
NYU Langone Health
New York, United States
Trial contact
Viola Sulollari
Wei Phin Tan, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.